Skip to main content
MyPeptideMatch logoMyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated February 2026

HCG Dosing Protocol: 5000 IU Vial — TRT Support & Post-Cycle Therapy Guide

Human chorionic gonadotropin (HCG) 5000 IU vial dosing guide for TRT co-administration, post-cycle therapy, male fertility, and hypogonadism protocols.

Quickstart highlights

HCG (human chorionic gonadotropin) is a 237-amino acid glycoprotein hormone produced by the placental syncytiotrophoblast, structurally homologous to LH.

  • Concentration: 5000 IU/mL (5000 IU vial + 1 mL bacteriostatic water).
  • At 5000 IU/mL: 250 IU = 0.05 mL, 500 IU = 0.1 mL, 2500 IU = 0.5 mL — use fine-calibration insulin syringe.
  • Coviello et al. 2005: 125 IU HCG EOD maintained intratesticular testosterone during testosterone administration.
  • Stable 60 days refrigerated after reconstitution — longer than most peptides.
  • FDA-approved (Pregnyl, Novarel) for cryptorchidism, male hypogonadism, and female infertility induction.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
TRT support (ongoing)Every other day (EOD)250 IU EOD — at 5000 IU/mL: draw 0.05 mL; co-administer with TRT to maintain testicular volume and intratesticular testosterone
TRT support (alt)Twice weekly500 IU 2x/week — draw 0.1 mL at 5000 IU/mL; common twice-weekly protocol with TRT
PCT (3-week course)Twice weekly x 3 weeks2500 IU 2x/week — draw 0.5 mL; PCT standard to stimulate testicular recovery post-anabolic cycle

Reconstitution steps

  1. Draw 1 mL bacteriostatic water; inject slowly down the vial wall.
  2. Swirl gently until the lyophilized powder dissolves completely (1–2 minutes); do not shake.
  3. Final concentration: 5000 IU/mL. At 5000 IU/mL: 250 IU = 0.05 mL, 500 IU = 0.1 mL, 2500 IU = 0.5 mL.
  4. Label with reconstitution date; refrigerate at 2–8 °C. Use within 60 days. HCG in solution is stable for 60 days refrigerated.

Supplies needed

pct_3wk-week plan

  • 2 vials
  • 6 syringes
  • 2 mL bac water
  • 6 alcohol swabs

trt_monthly-week plan

  • 1 vial
  • 15 syringes
  • 1 mL bac water
  • 15 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Maintain testicular Leydig cell activity, intratesticular testosterone production, and sperm maturation during exogenous testosterone therapy or anabolic steroid post-cycle recovery using regular HCG subcutaneous injections.

Off-cycle: TRT co-administration: continuous (no required off-cycle). PCT: 3-week course then transition to SERM (clomiphene/tamoxifen). Fertility: per physician protocol.

Storage & handling

Lyophilized: store below 25 °C or refrigerate. Reconstituted at 5000 IU/mL: refrigerate at 2–8 °C; use within 60 days. HCG in bacteriostatic water is stable for up to 60 days — unlike most peptides.

Injection & tracking tips

  • Inject subcutaneously (abdomen or thigh); HCG is not typically injected IM but SC is equally effective and less painful.
  • For TRT co-administration: inject HCG on the same days or alternating days as testosterone injections.
  • Use an insulin syringe with a 0.5 mL or 1 mL barrel — the small volumes (0.05–0.5 mL) require fine syringe calibration.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Monitor testicular volume (ultrasound or self-assessment) every 8 weeks during TRT co-administration.
  • Track LH, FSH, and total testosterone quarterly — HCG suppresses endogenous LH (via negative feedback at pituitary) but maintains testicular Leydig cell function.
  • If using for fertility: measure sperm count and motility at baseline and 12 weeks.
Log your cycle in the calculator →

How this works & references

HCG (human chorionic gonadotropin) is a 237-amino acid glycoprotein hormone produced by the placental syncytiotrophoblast, structurally homologous to LH. It binds the LH/CG receptor (LHCGR) on Leydig cells with higher affinity and longer half-life than LH (t½ 24–36 hours vs. LH t½ ~20 minutes). In men: (1) Stimulates Leydig cell testosterone synthesis; (2) Maintains intratesticular testosterone (ITT) levels essential for spermatogenesis; (3) Prevents testicular volume atrophy during exogenous androgen therapy. Coviello et al. (2005, J Clin Endocrinol Metab) demonstrated HCG 125 IU EOD maintained ITT during testosterone therapy. For PCT, HCG stimulates testicular steroidogenic recovery before SERM therapy normalizes HPG axis.

Frequently asked questions

Why is HCG used during TRT when testosterone already provides androgens?
Exogenous testosterone suppresses LH secretion via negative feedback, eliminating the signal for testicular Leydig cells to produce intratesticular testosterone (ITT). ITT concentrations are 50–100x higher than serum testosterone and are essential for spermatogenesis. Exogenous testosterone does not enter the testis efficiently. HCG (LH mimic) directly stimulates Leydig cells, maintaining ITT and preventing testicular atrophy and azoospermia.
What is the minimum effective HCG dose for TRT co-administration?
Coviello et al. (2005) showed 125 IU EOD (3.5 injections/week) maintained ITT at 98% of baseline during testosterone therapy. Doses as low as 100 IU EOD are effective. Higher doses (500+ IU EOD) are unnecessary for ITT maintenance and increase estradiol conversion via testicular aromatase, potentially worsening estrogen side effects.
How long should HCG PCT last before starting SERMs?
Standard PCT protocol: HCG 2500 IU 2x/week for 3 weeks (HCG phase), immediately followed by clomiphene 50 mg/day or tamoxifen 20 mg/day for 4–6 weeks (SERM phase). HCG stimulates testicular steroidogenic capacity; SERMs then restore HPG axis signaling. HCG should not continue during SERM therapy as it suppresses HPG axis recovery.
Does HCG require estrogen management?
At higher doses (500+ IU EOD), testicular aromatase increases estrogen production, potentially causing gynecomastia and water retention. Most men on TRT + low-dose HCG (250 IU EOD) do not require additional aromatase inhibitor. Estradiol monitoring (every 6–8 weeks) is recommended; if E2 exceeds 40–50 pg/mL with symptoms, consider anastrozole 0.25–0.5 mg 2x/week.
Is HCG FDA-approved?
Yes — Pregnyl and Novarel (HCG injection) are FDA-approved for: (1) Male cryptorchidism (undescended testicle) in prepubertal boys; (2) Hypogonadotropic hypogonadism in adult males; (3) Induction of ovulation in women with anovulation. Off-label use for TRT co-administration and PCT is extremely common in clinical practice.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.